EMEA-002532-PIP01-18

Key facts

Active substance
Phenobarbital
Therapeutic area
Neurology
Decision number
P/0422/2019
PIP number
EMEA-002532-PIP01-18
Pharmaceutical form(s)
Oral suspension
Condition(s) / indication(s)
Treatment of epilepsy
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Proveca Limited

E-mail: simon@proveca.com
Tel. +44 1614682627

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating